At Deakin’s School of Medicine, The Institute for Mental and Physical Health and Clinical Translation (IMPACT) develops new and effective responses to mental and physical health for our community. We use cutting-edge approaches to translate our medical research from the laboratory to real-world solutions.
Find out moreOur team of over 300 researchers has a shared aim to improve the quality of life of our global community. We work to develop innovative diagnostics, treatments and therapies for mental health conditions and chronic diseases.
Our multi-disciplinary, collaborative and responsive approach allows us to quickly translate our biomedical discoveries, made at the science lab bench, into treatment possibilities at the bedside of our trial patients and the broader community.
Find out more
In our state-of-the-art biomedical and clinical research labs, we explore the molecular basis of health and disease, such as basic gene discovery and molecular analysis.
We explore the complex interrelation between mental and physical health, including identifying and modifying factors in our environment, diet and chronic diseases.
We work to find new approaches to treating mental health disorders such as depression and bipolar disorder by discovering novel drugs or repurposing pre-existing ones used for other conditions.
See what we've been up to lately
New research has found that people with genetic risk for depression have a greater chance of developing certain types of heart disease, pointing to the opportunity for dual-purpose prevention...
The 2025 IMPACT Showcase brought together researchers from across the institute to celebrate the inspiring work that’s shaping better health outcomes. This year’s theme, “From Silos to Synergy” emphasised...
Most of us know that junk food isn’t great for our health. But growing scientific evidence suggests that ultra-processed foods (UPFs) may be doing more harm than we realise,...
Looking for some more good news?
Find out moreStay updated on the latest from IMPACT by subscribing to our newsletter.